[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349029-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349029-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","silencing-of-small-nuclear-ribonucleoprotein-polypeptide-b-inhibits-the-progression-of-esophageal-squamous-cell-carcinoma","Silencing of small nuclear ribonucleoprotein polypeptide B inhibits the progression of esophageal squamous cell carcinoma","","Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis. Small nuclear ribonucleoprotein polypeptide B (SNRPB) has been linked to cancer progression, but its role in ESCC was unclear. This study assessed SNRPB expression and clinical relevance using bioinformatics, TCGA, and institutional data. SNRPB knockdown via lentivirus-based shRNA in ESCC cell lines inhibited proliferation, caused cell cycle arrest, and promoted apoptosis, indicating SNRPB as a potential prognostic biomarker and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/silencing-of-small-nuclear-ribonucleoprotein-polypeptide-b-inhibits-the-progression-of-esophageal-squamous-cell-carcinoma/349029/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/silencing-of-small-nuclear-ribonucleoprotein-polypeptide-b-inhibits-the-progression-of-esophageal-squamous-cell-carcinoma/349029.png","ImageObject",300,407,{"name":42,"@type":43},"Taylor Morgan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about SNRPB in ESCC?","Question",{"text":63,"@type":64},"The study investigates the expression pattern and functional significance of SNRPB in esophageal squamous cell carcinoma, and whether it contributes to tumor progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was SNRPB expression evaluated in ESCC?",{"text":68,"@type":64},"SNRPB expression was analyzed using bioinformatics tools, immunohistochemical staining of ESCC and adjacent tissues, and survival/clinicopathologic association using public and institutional datasets.",{"name":70,"@type":61,"acceptedAnswer":71},"What effects did SNRPB silencing have on ESCC cells?",{"text":72,"@type":64},"Lentivirus-mediated shRNA knockdown of SNRPB significantly inhibited cell proliferation, induced cell cycle arrest, and promoted apoptosis, with molecular changes consistent with these processes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349029,1790300748,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","ONCOLOGY LETTERS 31: 206, 2026  \nSilencing of small nuclear ribonucleoprotein polypeptide B inhibits the progression of esophageal squamous cell carcinoma  \nHAIYANG GUO1* , JI ZUO1* , GUANGBING HU1* , YONG TANG1 , LIUYI LU2 , ZICHEN LUO1 , XINRUI CHEN1 , XIAOBO WANG1 and XIANFEI WANG1,3  \n1Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China; 2  \nDepartment of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China; 3Digestive Endoscopy Center, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China  \nReceived September 16, 2025; Accepted February 9, 2026  \nDOI: 10. 3892/ol.2026.15561  \nAbstract. Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis. Small nuclear ribonucleoprotein polypeptide B (SNRPB) has been implicated in the progression of various types of cancer; however, the specific role of this protein in ESCC remains unclear. The present study aimed to investigate the expression and functional significance of SNRPB inESCC. Bioinformatics analysis was performed to assess SNRPB expression and its clinical relevance in ESCC. Immunohistochemical staining of ESCC tissue samples demonstrated significantly elevated SNRPB expression in tumor tissues, compared with adjacent non‑cancerous esophageal tissues. Analysis of public database (TCGA) and institutional clinical data revealed that high SNRPB expression was associated with poor prognosis and advanced clinical stage (T stage), respectively. To evaluate the functional role of SNRPB, a lentivirus‑based short hairpin RNA vector was used to inhibit endogenous SNRPB expression in ESCC cell lines. Functional assays, including colony formation, flow cytometry and western blot analysis, demonstrated that SNRPB knockdown significantly inhibited cell proliferation, induced cell cycle arrest and promoted apoptosis. Moreover, molecular analysis indicated that SNRPB knockdown led to modulation of the cell cycle and proteins associated with apoptosis. These findings suggested that SNRPB is a key regulator of ESCC progression, through impacting cell proliferation and apoptosis. Collectively, results of the present study demonstrated that SNRPB may act as  \nCorrespondence to: Dr Xianfei Wang, Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, 1 Maoyuan South Road, Nanchong, Sichuan 637000, P.R. China  \nE‑mail: [2750853458@qq.com](2750853458@qq.com)  \n*Contributed equally  \nKey words: esophageal squamous cell carcinoma, SNRPB, cell cycle, apoptosis  \na potential prognostic biomarker and therapeutic target for ESCC.  \nIntroduction  \nEsophageal cancer is among the leading causes of cancer‑related mortality worldwide (1) . Each year, ~16,120 individuals in the United States are diagnosed with esophageal cancer (2). Despite advances in diagnostic techniques and treatment options, the prognosis for individuals with esophageal cancer remains unfa‑ vorable, with 5‑year survival rates typically ranging between 15 and 25%(3,4) . Notably, esophageal squamous cell carcinoma (ESCC) accounts for ~90% of cases of esophageal cancer (5) . However, despite advances in screening and therapeutic inter‑ ventions, patient outcomes remain poor, and a considerable subset of patients continues to experience disease recurrence or progression (6,7). Therefore, the discovery of novel targets for the management of ESCC are required.  \nIn the search for such novel targets, dysregulation of fundamental cellular processes such as alternative splicing has emerged as a key area of investigation in oncology. Alternative splicing is a pivotal regulatory mechanism that governs gene expression and increases protein diversity (8) . This process is carried out by the spliceosome, a complex ribonucleoprotein machine. Small nuclear ribonucleoprotein polypeptides B (SNRPB) and B' are essential components of this machiner","cbCaisiW9sRbUAb5","https://ap.wps.com/l/cbCaisiW9sRbUAb5","pdf",6184563,"English","# Abstract\n# Introduction\n# Materials and methods","[{\"question\":\"What question does the study address about SNRPB in ESCC?\",\"answer\":\"The study investigates the expression pattern and functional significance of SNRPB in esophageal squamous cell carcinoma, and whether it contributes to tumor progression.\"},{\"question\":\"How was SNRPB expression evaluated in ESCC?\",\"answer\":\"SNRPB expression was analyzed using bioinformatics tools, immunohistochemical staining of ESCC and adjacent tissues, and survival/clinicopathologic association using public and institutional datasets.\"},{\"question\":\"What effects did SNRPB silencing have on ESCC cells?\",\"answer\":\"Lentivirus-mediated shRNA knockdown of SNRPB significantly inhibited cell proliferation, induced cell cycle arrest, and promoted apoptosis, with molecular changes consistent with these processes.\"}]","Silencing of small nuclear ribonucleoprotein polypeptide B inhibits the progression of esophageal squamous cell carcinoma | PDF",1790081262,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66d8238dd9d736a7519bd88b76816c44.webp",983,1357,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d65f1bbd13280f533b8a0c659d33e9a3.webp",982,1356,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd41c08a8a46fabb19e4db7cfb132c61.webp",981,1354,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35ade03d56e8ab5ac8044a34e112e0b3.webp",980,1353]